Allstate Corporation (ALL) reported mixed first-quarter financial results on Thursday, with adjusted earnings per share significantly exceeding analyst expectations while total revenue fell short of consensus estimates. The company delivered an adjusted EPS of $10.65 for the quarter, surpassing the average analyst estimate of $7.24 per share according to the provided text. However, the report notes that revenue missed expectations despite notable improvements in underwriting performance driven by a better combined ratio across personal lines brands.
The improvement in underwriting results was primarily attributed to lower catastrophe losses and higher underwriting income in both auto and homeowners insurance segments. Specifically, catastrophe losses dropped 44% year-over-year, which substantially contributed to improved underwriting income and overall better results for the Property-Liability and homeowners business lines. These favorable underwriting dynamics allowed the company to offset revenue misses with strong profitability metrics.
Despite the headline numbers, analysts focused on the divergence between earnings growth and top-line revenue decline, suggesting that pricing or market share headwinds may have limited premium volume growth in a competitive environment. The article highlights Allstate's ability to manage loss costs effectively even when faced with challenging macroeconomic conditions or specific event risks, positioning the insurer as resilient despite missing on pure revenue targets.
📈 Q1 Adjusted EPS of $10.65 significantly beat analyst consensus of $7.24.
💵 Revenue missed expectations despite strong earnings and improved underlying combined ratio.
🚗 Auto, Homeowners, and Catastrophe results all showed positive underwriting or loss improvements.
📉 Mixed overall performance due to the revenue miss offsetting other gains.
📊 Report published on April 29, 2026, by Liz Kiesche for Seeking Alpha.
📈 Allstate (ALL) Q1 adjusted EPS of $10.65 beat analyst consensus estimates which stood at $7.24.
💵 Company revenue missed expectations despite strong earnings performance.
🛠️ The insurer reported an improvement in its underlying combined ratio across personal lines.
🚗 Auto insurance underwriting income increased, contributing to overall operational strength.
🏠 Homeowners insurance also posted higher underwriting income compared to previous periods.
⚡ Catastrophe losses decreased by 44% year-over-year, positively impacting Property-Liability results.
📉 Despite the EPS beat, mixed results occurred due to the revenue miss offsetting other gains.
📊 Seeking Alpha published this earnings report on April 29, 2026.
👩💼 The analysis was written by Liz Kiesche for Seeking Alpha.
🏢 Allstate Corporation trades on the NYSE under the ticker symbol ALL.
Bullish Signals
- EPS of $10.65 beat the $7.24 estimate.
- Combined ratio improved across all personal lines.
- Catastrophe losses dropped 44% year-over-year.
- Underwriting income rose in auto and homeowners.
Risk Factors
- Revenue missed expectations despite beating EPS.
- Lower catastrophe losses may hide future risk.
- Improvement likely due to one-time loss drops.
Bullish Signals
- Adjusted EPS of $10.65 significantly exceeded the average analyst estimate of $7.24.
- Underlying combined ratio improved across all personal lines, including auto and homeowners segments.
- Catastrophe losses dropped 44% year-over-year, which directly contributed to improved underwriting income.
- Higher underwriting income was generated specifically in both auto and homeowners insurance segments.
Risk Factors
- Revenue missed analyst expectations despite adjusted EPS beating consensus, indicating top-line weakness.
- Catastrophe losses dropped 44% year-over-year, which may mask potential exposure to emerging weather events in future quarters.
- The improvement in underwriting results could be driven by higher catastrophe losses falling off the books rather than fundamental business strength.
Allstate Corporation reported first-quarter net income of $2.46 billion, translating to profit per share of $9.25, which significantly exceeded Wall Street expectations set by 10 analysts at $7.43 per share. The company's adjusted earnings per share were even higher at $10.65 after accounting for one-time gains and costs. While the insurer posted revenue of $16.94 billion in the period, its adjusted revenue of $17.35 billion fell short of forecasts, with three analysts from Zacks expecting approximately $17.7 billion.
Following the earnings announcement, Allstate shares rose 2% at the start of the trading session and closed at $212.33 in the final minutes of Wednesday's trading. This performance contributed to a stock price increase of nearly 7% over the last 12 months, outpacing the S&P 500 index, which gained 4% during the same period. The results highlight Allstate's strong profitability in Q1 despite some shortfalls in adjusted revenue estimates.
The article was generated by Automated Insights using data from Zacks Investment Research and provides a snapshot of the company's financial performance relative to market expectations. The ticker ALL is the primary focus of this report, detailing specific earnings figures, analyst projections, and stock price movements that are relevant for investors tracking the insurance sector.
💰 EPS hit $9.25, beating analyst expectations significantly.
📈 Shares rose 7% in a year to trade at $212.33.
📉 Adjusted revenue of $17.35B fell short of forecasts.
📈 Allstate reported first-quarter net income of $2.46 billion, surpassing Wall Street expectations.
💰 Earnings per share reached $9.25, with adjusted earnings of $10.65 after accounting for one-time gains and costs.
📉 Adjusted revenue totaled $17.35 billion, falling short of analyst forecasts which averaged $17.7 billion.
📊 Gross revenue for the period was reported at $16.94 billion.
📈 Stock performance shows Allstate shares are up nearly 7% over the last 12 months, trading at $212.33 in the final minutes of Wednesday's session.
🔍 Analysts surveyed by Zacks Investment Research had predicted earnings of $7.43 per share before Allstate's actual report.
📉 The company has outperformed the S&P 500 index this year with a 2% gain compared to the index's 4% rise.
🤖 This news report was generated by Automated Insights using financial data provided by Zacks Investment Research.
Bullish Signals
- Net income hit $2.46 billion, beating Wall Street estimates.
- EPS of $10.65 surpassed analyst expectation of $7.43.
- Allstate shares gained 2% YTD and rose nearly 7% to $212.33.
- Revenue reached $16.94 billion demonstrating strong top-line performance.
Risk Factors
- Adjusted revenue of $17.35B missed analyst consensus.
- Company disappointed Wall Street with lower-than-expected top-line growth.
Bullish Signals
- First-quarter net income reached $2.46 billion, significantly beating Wall Street estimates.
- Adjusted earnings per share were $10.65, surpassing the average analyst expectation of $7.43.
- Allstate shares have gained 2% year-to-date and increased nearly 7% over the last 12 months to a price of $212.33.
- The company reported revenue of $16.94 billion during the period, demonstrating strong top-line performance.
Risk Factors
- Adjusted revenue of $17.35 billion fell short of Street forecasts, with only three analysts expecting $17.7 billion.
- The company missed analyst expectations on the adjusted revenue metric despite reporting strong net income.
Barclays has maintained its Sell rating on Allstate Corp. (ALL), with analyst Alex Scott setting a price target of $208. The report, released on Thursday, April 9, comes from Scott, who focuses on the Financial sector and covers stocks including Prudential Financial and Arthur J Gallagher & Co. According to data provided by TipRanks, Scott has historically demonstrated an average return of 4.5% with a 47.04% success rate on his recommended stocks, though the article notes this content is from third parties and has not been reviewed by The Globe and Mail.
Despite Barclays' negative stance, Allstate maintains a broader analyst consensus rating of Moderate Buy, supported by an average price target of $239.00. The company's recent financial performance includes quarterly revenue of $16.59 billion and net profit of $3.83 billion for the quarter ending December 31, reflecting growth from the prior year where revenue was $16.34 billion and net profit was $1.93 billion. The article also contextualizes this rating with other recent market movements involving Allstate, such as Mizuho lowering its price target to $265 from $281, Goldman Sachs downgrading the stock to Neutral from Buy, and reports on January catastrophe losses totaling $140 million.
The summary emphasizes the discrepancy between Barclays' individual Sell recommendation versus the aggregate market sentiment. The text further highlights that the provided content is syndicated and includes a disclaimer stating that The Globe and Mail has not reviewed, approved, or endorsed the material, while also noting potential compensation for the placement of such content. Additional headlines linked to the article touch on broader financial topics including Meta's downgrade, MongoDB upgrades, oil price impacts on Canadian stocks, and insights into REITs, though these are presented as separate market updates rather than direct commentary on Allstate's fundamental situation.
📉 Barclays analyst Alex Scott maintains a Sell rating on Allstate with $208 price target.
📈 Allstate reported Q1 revenue of $16.59B and net profit of $3.83B, up YoY.
⚠ Analyst consensus rates Allstate Moderate Buy vs. Barclays Sell with higher valuation targets.
📉 Barclays analyst Alex Scott maintains a Sell rating on Allstate (ALL) with a price target of $208.00.
🔍 Scott focuses on the Financial sector, including stocks like Prudential and Arthur J Gallagher & Co.
📊 His track record shows a 4.5% average return and a 47.04% success rate on recommended stocks.
➕ The analyst consensus for Allstate is Moderate Buy with a higher price target of $239.00.
💰 In the most recent quarter, Allstate reported revenue of $16.59 billion and net profit of $3.83 billion.
📈 This represents growth from the previous year's revenue of $16.34 billion and profit of $1.93 billion.
⚠️ The article includes various other headlines regarding Allstate, including a downgrade at Goldman Sachs.
🛑 Other related updates mention price target adjustments by Mizuho and catastrophe loss reports.
📝 This content is sourced from third-party materials and has not been reviewed or endorsed by the publication.
Bullish Signals
- Net profit surged from $1.93B last year to $3.83B.
Risk Factors
- Barclays rates Sell with $208 target vs $239 consensus.
- Mizuho cut target from $281 to $265 due to valuation concerns.
- Goldman downgraded Allstate to Neutral, showing sentiment divergence.
- $140M January catastrophe losses may impact future reserves.
Bullish Signals
- The company demonstrated substantial improvement in profitability, with net profit increasing from $1.93 billion last year to $3.83 billion in the most recent quarter ending December 31.
Risk Factors
- Barclays maintains a Sell rating on Allstate with a price target of $208.00, significantly below the analyst consensus target of $239.00.
- Mizuho previously lowered its price target from $281 to $265, indicating ongoing concern among analysts regarding the stock's valuation.
- Allstate downgraded to Neutral from Buy at Goldman Sachs, showing a divergence in investor sentiment despite reported earnings growth.
- The company reported January catastrophe losses of $140M, which may impact future reserve calculations and profitability.
Allstate Corporation (ALL), based in Northbrook, Illinois, holds a market capitalization of $54.6 billion and operates as a U.S.-based insurer offering property and casualty insurance across the United States and Canada. The company is scheduled to release its fiscal Q1 2026 earnings report after the market closes on Wednesday, April 29. Ahead of this announcement, analysts forecast an adjusted earnings per share (EPS) of $7.70 for the quarter, representing a significant increase of 118.1% compared to the $3.53 reported in the same period last year. Allstate has exceeded Wall Street's earnings estimates in each of the last four quarters, demonstrating consistent performance despite broader market conditions.
Looking at the full fiscal picture for 2026, analysts expect the insurer to report an adjusted EPS of $26.15, which is projected to be down 24.9% from the $34.83 reported in fiscal 2025. Over the past 52 weeks, Allstate shares have gained 14.8%, underperforming compared to the S&P 500 Index's 35.8% increase and the State Street Financial Select Sector SPDR ETF's (XLF) 16.6% return. The company saw notable momentum following its Q4 2025 results released on February 4, where shares rose 3.9% and adjusted EPS hit $14.31, significantly beating estimates. Investor sentiment was reinforced by capital return initiatives, including an 8% dividend hike to $1.08 per share and a new $4 billion share buyback program, alongside improved underwriting performance such as Property-Liability income reaching $4.01 billion.
The consensus analyst rating for Allstate remains cautiously optimistic, characterized as a "Moderate Buy." Of the 24 analysts covering the stock, 12 have issued "Strong Buy" recommendations, while nine suggest a "Hold," one is "Moderate Buy," and two are "Strong Sell." The average price target among these analysts stands at $241.59, implying potential upside of 14.3% from current levels. Despite the positive outlook following recent strong quarterly results and capital initiatives, investors will be closely watching how Q1 2026 performance plays out against the backdrop of lower full-year fiscal expectations for 2026 compared to the prior year.
📅 Allstate will report Q1 2026 results on Wednesday, April 29.
💰 Analysts forecast an adjusted EPS of $7.70, up 118.1% year-over-year.
📉 Stock gained 14.8% over 52 weeks while lagging the S&P 500.
🎯 Average analyst price target suggests a potential 14.3% upside.
📅 Allstate Corporation (ALL) is expected to announce its fiscal Q1 2026 results after market close on Wednesday, Apr. 29.
💰 Analysts forecast an adjusted EPS of $7.70 for the upcoming quarter, representing a significant 118.1% increase from the year-ago quarter's $3.53.
📈 The company has surpassed Wall Street's earnings estimates in four consecutive quarters leading up to this report.
💸 For fiscal 2026, full-year analysts expect an adjusted EPS of $26.15, which would be down 24.9% from the previous year's $34.83.
📉 Stock performance over the past 52 weeks shows a 14.8% gain for Allstate, lagging behind both the S&P 500 (35.8%) and the Financial Select Sector ETF (16.6%).
🚀 Previous Q4 2025 results saw shares rise 3.9% on adjusted EPS of $14.31, with capital return initiatives including an 8% dividend increase to $1.08 per share and a new $4 billion buyback program.
🛠️ Underwriting performance showed significant improvement in Q4 2025, with Property-Liability income reaching $4.01 billion and Protection Auto income at $1.85 billion.
📊 Investor sentiment is cautiously optimistic, reflected by a "Moderate Buy" consensus rating among the 24 analysts currently covering the stock.
👥 The analyst breakdown includes 12 "Strong Buy" recommendations, nine "Hold" suggestions, and two "Strong Sell" ratings.
🎯 The average analyst price target is set at $241.59, suggesting a potential upside of 14.3% from current market levels.
🏢 Allstate operates through multiple segments across the United States and Canada via agents, contact centers, and digital platforms under several well-known brands.
💵 The company currently holds a market capitalization of $54.6 billion.
Bullish Signals
- Allstate shares rose 3.9% after Q4 2025 results beat EPS estimates.
- 8% dividend increase to $1.08 and $4B buyback boosted investor sentiment.
- Property-Liability income jumped to $4.01B; Protection Auto income reached $1.85B.
- Allstate surpassed earnings estimates in four consecutive quarters.
- Analysts rate stock 'Moderate Buy' with majority recommending 'Strong Buy'.
- $241.59 average target implies 14.3% upside from current levels.
Risk Factors
- EPS projected to drop 24.9% to $26.15 by fiscal 2026.
- Allstate shares underperformed the market with 14.8% vs S&P 500 35.8%.
- Analysts divided on sentiment with nine holding or selling against twelve buying.
- Article contains irrelevant promotional content distracting from Allstate performance.
- Q1 2026 earnings expected to show significant EPS decline.
Bullish Signals
- Shares of Allstate rose 3.9% following its Q4 2025 results on Feb. 4, with adjusted EPS of $14.31 far exceeding the analyst estimate and rising from $7.67 a year earlier.
- Investor sentiment was further boosted by capital return initiatives, including an 8% dividend increase to $1.08 per share and the announcement of a $4 billion share buyback program.
- Significantly improved underwriting performance such as Property-Liability income jumping to $4.01 billion and Protection Auto income rising to $1.85 billion.
- The Northbrook, Illinois-based company has surpassed Wall Street's earnings estimates in the last four quarters before its fiscal Q1 2026 results announcement.
- Analysts have a 'Moderate Buy' rating overall on Allstate stock, with 12 out of 24 analysts recommending 'Strong Buy'.
- The average analyst price target is $241.59, indicating a potential upside of 14.3% from the current levels.
Risk Factors
- For fiscal 2026, analysts expect adjusted EPS of $26.15, representing a significant 24.9% decline from the $34.83 reported in fiscal 2025.
- Allstate shares are lagging the broader market, having returned only 14.8% over the past 52 weeks compared to the S&P 500 Index's 35.8% increase and the Financial Select Sector SPDR ETF's 16.6% return.
- Only 9 out of 24 analysts covering the stock suggest a 'Hold' or 'Strong Sell', while 12 recommend 'Strong Buy' and one recommends 'Moderate Buy', indicating mixed sentiment with bearish voices present.
- The article includes irrelevant promotional content for unrelated stocks like Google and Penny Stock Xiao-I, which distracts from Allstate's specific performance metrics.
- Shares of Allstate rose following Q4 2025 results, but the upcoming Q1 2026 earnings are expected to show a significant decline in adjusted EPS compared to fiscal 2025.
Allstate Corporation (ALL) is currently trading near the top of its 52-week range and above its 200-day simple moving average, reflecting mixed market sentiment despite a recent price increase. Shares have risen $2.17 since the previous market close, representing a 1.04% rise, with an additional $1.47 gain observed in after-hours trading. The company operates within the property and casualty insurance sector through multiple segments including Allstate Protection, which covers private passenger auto, homeowners, and commercial insurance under brands like Allstate and National General; Allstate Health and Benefits, offering voluntary benefits and life insurance products; and others focused on protection services and run-off claims related to asbestos and environmental exposures. Founded in 1931 and headquartered in Northbrook, IL, Allstate is classified as a large capitalization company with a market cap between $10 billion and $200 billion.
Analyst opinions regarding Allstate remain conflicted, with a range of rating adjustments reflecting divergent views on the stock's future performance. Recent activity includes Mizuho lowering its price target to $265 from $281 and TD Cowen issuing a Hold rating, while Goldman Sachs downgraded the stock to Neutral. Conversely, several firms have raised their price targets or upgraded ratings; Keefe Bruyette increased its target to $260 from $254, Mizuho raised its price target back to $281 from $255, Citi boosted its target to $221 from $216, Wells Fargo adjusted its target upward to $228 from $223, Goldman Sachs raised its price target to $238 from $227, and Piper Sandler assigned a Buy rating. JPMorgan also increased its price target to $263 from $260. Despite these mixed signals, KBW maintains its Buy rating for Allstate, and Barclays retains its Sell rating.
Financial performance data highlights significant growth in certain metrics over the past year while Q4 figures remain steady compared to the previous quarter. Total revenue is reported at $67.69 billion on a one-year basis and $17.34 billion in the fourth quarter, with revenue increasing 5.58% since last year but holding flat since the last quarter. Net income showed substantial growth, rising 120.31% since last year and holding flat for the quarter, while earnings per share reached $38.06 on a one-year basis and $14.37 in Q4, representing a 123.99% increase year-over-year. Operational updates from Allstate also disclosed January catastrophe losses of $140 million in one report and $175 million in another, alongside monthly estimates for policy growth.
🚀 ALL stock at 52-week high, up 1.04% since last close.
💰 Revenue $67.69B annually; Q4 earnings $17.34B.
📈 Net income surged 120.31% YoY with EPS up 123.99%.
⚠ Mixed analyst ratings amid privacy lawsuit and catastrophe losses.
🚀 ALL stock trades near its 52-week high, rising 1.04% since last market close.
🏦 Allstate Corp operates in property and casualty insurance across multiple segments including auto, homeowners, and commercial lines.
⚖️ The company was founded in 1931 and is headquartered in Northbrook, Illinois.
📊 Total revenue reached $67.69 billion for the year and $17.34 billion for the fourth quarter.
📈 Net income surged 120.31% year-over-year while EPS jumped 123.99% during the same period.
⚠️ Analyst opinions are mixed, with Mizuho lowering its price target and Barclays maintaining a Sell rating.
💰 Goldman Sachs raised its price target to $238 from $227 and Wells Fargo increased its target to $228.
🔒 Allstate is facing a privacy lawsuit regarding the tracking of drivers on cellphones.
🌪️ The company reported January catastrophe losses of $140 million to $175 million in various updates.
🛡️ Business segments include Protection, Protection Services, Health and Benefits, Run-off Property-Liability, and Corporate/Other.
⚖️ KBW maintains a Buy rating despite other firms holding neutral or conflicted positions on the stock.
📉 Some analysts are bearish while others remain bullish, reflecting market uncertainty in the financial sector.
Bullish Signals
- ALL trades near 52-week high above 200-day moving average.
- Stock gained $2.17 (1.04%) after regular hours close.
- After-hours trading added $1.47 to stock price.
- Net income surged 120.31% with EPS up 123.99% YoY.
- Revenue reached $67.69 billion, up 5.58% from prior year.
- Goldman Sachs raised price target to $238 from $227.
- JPMorgan increased price target to $263 from $260.
- Piper Sandler upgraded Allstate to Buy rating.
- Keefe Bruyette raised price target to $260 from $254.
- Citi increased price target to $221 from $216.
Risk Factors
- Mizuho cut price target from $281 to $265.
- Goldman downgraded to Neutral amid mixed analyst sentiment.
- Barclays maintains Sell Rating vs bullish upgrades.
- Privacy lawsuit filed over cellphone tracking reports.
- January catastrophe losses totaled $140M then $175M.
- Revenue flat despite year-over-year increase growth.
- Analysts conflicted with mixed opinions alongside Primerica.
- Stock volatile amid macro concerns like oil prices.
Bullish Signals
- Allstate Corporation (ALL) is trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong technical momentum.
- The stock price has risen $2.17 since market close, representing a 1.04% gain in regular hours.
- After-hours trading saw an additional $1.47 increase in the stock price, further supporting bullish sentiment.
- Net Income surged by 120.31% year-over-year and EPS increased by 123.99%, demonstrating significant profitability growth.
- Revenue for the last year reached $67.69 billion with a 5.58% increase compared to the prior year.
- Goldman Sachs raised its price target to $238 from $227, signaling positive analyst outlook.
- JPMorgan increased its price target to $263 from $260, showing confidence in Allstate's growth potential.
- Piper Sandler upgraded Allstate to a Buy rating, reflecting favorable sentiment among major financial institutions.
- Keefe Bruyette raised the price target to $260 from $254, indicating continued upside expectations.
- Citi increased its price target to $221 from $216, further validating positive market positioning.
Risk Factors
- Allstate received a price target lowered to $265 from $281 at Mizuho, indicating negative sentiment from the analyst firm.
- The stock was downgraded to Neutral from Buy by Goldman Sachs and also received a Hold rating from TD Cowen and Morgan Stanley.
- Barclays maintained its Sell Rating for Allstate, contrasting with some other bullish upgrades.
- Allstate faces a privacy lawsuit regarding the cellphone tracking of drivers as reported by Reuters.
- The company experienced January catastrophe losses of $140M and subsequently another report showed $175M in catastrophe losses, impacting earnings.
- Total revenue held flat since last quarter despite a year-over-year increase, suggesting limited growth momentum in the recent period.
- Analysts remain conflicted on Allstate with opinions mixed alongside competitors like Primerica.
- The stock price has risen significantly but faces volatility as broader markets react to macro concerns like oil prices and geopolitical tensions.
Allstate Corporation (ALL) has received a buy rating reaffirmation from Seeking Alpha, aligning with the broader bullish consensus on Wall Street as of April 4, 2026. The article identifies key drivers for potential upside in fiscal year 2025, specifically highlighting new policies being written, strong operating margins, and a low dividend payout ratio that could enhance shareholder returns. Allstate maintains its status as one of the top ten property and casualty (P&C) insurers in the United States, though the analysis notes that major peers like Progressive currently outperform it on specific metrics.
A significant portion of the discussion focuses on risk management within the sector, particularly regarding catastrophic loss claims which impacted the first quarter of fiscal year 2025. The author uses an analogy comparing the insurance business to sailing, emphasizing the need for experienced leadership to anticipate storms and sudden market changes rather than relying solely on calm periods. Regulatory risks are also flagged as a key area requiring attention alongside underwriting performance.
The piece is authored by Albert Anthony, a veteran investment analyst and author who brings extensive experience from both financial firms and his own boutique equities research firm, Albert Anthony & Company. His analysis relies on publicly available data and fundamental technical analysis methods to provide actionable insights for long-term investors. The author explicitly states no material conflict of interest, holding no stock positions in the mentioned companies and receiving no compensation from them, ensuring the commentary remains independent despite the platform's role as a third-party publisher.
📈 Allstate maintains a buy rating backed by strong FY2025 policies and margins.
⚠ Catastrophic claims and regulatory issues pose current risks to the insurer.
🏢 Allstate remains a top-10 US P&C player but lags some peers.
📈 Allstate Corporation (ALL) stock receives a buy rating reaffirmation from analysts, aligning with the current bullish consensus on Wall Street.
💰 Investors see upside potential driven by new policies written in fiscal year 2025, strong operating margins, and a low dividend payout ratio.
🏢 Allstate remains within the top 10 property and casualty insurers in the US but is currently outperformed by some major peers like Progressive on specific metrics.
⚠️ The company faces risks related to catastrophic loss claims, such as those experienced in the first quarter of fiscal year 2025, along with associated regulatory challenges.
🌩️ Analyst Albert Anthony uses a sailing analogy to illustrate that experienced investors should anticipate potential storms or sudden changes in the insurance sector.
✍️ The analysis is provided by Albert Anthony, who writes under the pen name of an Amazon author and has been a contributor to Seeking Alpha since 2023.
🎓 Anthony holds certifications from Microsoft, CompTIA, and the Corporate Finance Institute, with a specialization in risk management.
🛡️ His boutique equities research firm, Albert Anthony & Company, operates under trade names in both the US and Croatia.
⚠️ The author notes that Allstate is not rated as highly on certain metrics by analysts who have compared its performance to Progressive.
💬 Seeking Alpha's standard disclosures state that past performance does not guarantee future results and that no specific investment advice is being given.
Bullish Signals
- Allstate buy rating reaffirmed with bullish consensus.
- FY25 policies drive upside supported by strong margins.
- Allstate ranks in top 10 US P&C insurers.
Risk Factors
- Allstate underperforms peers in some metrics despite buy rating.
- Company faces catastrophic loss risks, especially in FY25 Q1.
- Regulatory issues identified as downside catalysts for the business.
Bullish Signals
- Allstate Corp. has its buy rating reaffirmed, aligning with the latest bullish Wall Street consensus for the stock.
- Upside potential is identified from new policies written in FY25, supported by a strong operating margin and a low dividend payout ratio.
- Allstate remains ranked among the top 10 Property & Casualty insurers in the US, demonstrating market leadership.
Risk Factors
- Despite reaffirming a buy rating, Allstate is acknowledged as being outperformed in some metrics by major peers like Progressive, indicating relative weakness.
- The company faces specific risks related to catastrophic loss claims, particularly noted as occurring during FY25 Q1.
- Regulatory risk is explicitly identified as a downside catalyst impacting the business.
In the latest trading session, Allstate Corporation (ALL) shares closed at $204.10, representing a decline of 1.56% from the previous day's price. This performance lagged behind the broader market indices during the period, with the S&P 500 advancing by 0.72%, the Dow Jones Industrial Average rising 0.48%, and the Nasdaq Composite gaining 1.16%. Over the preceding month, Allstate shares experienced a steeper correction of 2.94%, yet still outperformed the broader Finance sector's monthly loss of 5.41% and the S&P 500's decline of 4.99%.
The investment community is focused on the company's upcoming earnings release scheduled for April 29, 2026. Analysts anticipate the company will report an earnings per share (EPS) of $7.7, which would represent a significant 118.13% increase compared to the same quarter in the previous year. Additionally, quarterly revenue is expected to reach $17.72 billion, up 5.49% from the year-ago period. On an annualized basis, Zacks Consensus Estimates forecast full-year earnings of $26.01 per share and revenue of $72.87 billion, projecting a decrease of 25.32% in EPS but an increase of 7.4% in revenue compared to the prior year.
Valuation metrics suggest Allstate may be trading at a discount relative to its peers. The stock currently holds a Forward P/E ratio of 7.97, which is lower than the industry average of 10.17. Furthermore, the company's Price-to-Earnings-Growth (PEG) ratio stands at 0.42, significantly below the sector average of 2.01, indicating growth expectations are factored into the valuation differently. Based on recent analyst forecast revisions reflecting positive alterations and business trends, Allstate maintains a Zacks Rank of #1 (Strong Buy). The company's broader industry, Insurance - Property and Casualty within the Finance sector, holds a Zacks Industry Rank of 38, placing it in the top 16% among over 250 industries. Research indicates that such high-ranked sectors historically outperform the bottom half by a factor of 2 to 1.
📉 Allstate stock fell 1.56% to $204.10, outperforming the declining Finance sector by 3%.
🚀 Strong Buy Zacks Rank #1 predicts average annual returns of +25% historically.
💰 Valuation metrics show Forward P/E of 7.97 and low PEG ratio of 0.42.
📉 Allstate stock closed at $204.10, down 1.56% despite broader market gains including the S&P 500's 0.72% increase.
📊 The insurer saw a monthly decline of 2.94%, outperforming the Finance sector which fell 5.41%.
📅 Earnings are expected on April 29, 2026, with analysts forecasting EPS of $7.70 and revenue of $17.72 billion.
📈 Yearly consensus estimates predict earnings of $26.01 per share and revenue of $72.87 billion.
🔄 Recent positive analyst revisions suggest optimism about short-term business trends and profitability.
🚀 Allstate holds a Zacks Rank of #1 (Strong Buy), based on quantitative models linking estimate changes to momentum.
💰 The company trades at a Forward P/E ratio of 7.97, below the industry average of 10.17.
📊 ALL's PEG ratio is 0.42, significantly lower than the industry average of 2.01.
🏆 The Insurance - Property and Casualty industry ranks in the top 16% among over 250 industries.
📈 Historical data shows stocks with a #1 Zacks Rank have delivered an average annual return of +25% since 1988.
Bullish Signals
- EPS expected at $7.7 on April 29, 2026, a 118.13% annual rise.
- Quarterly revenue forecast at $17.72B, up 5.49% from last year.
- Allstate holds Zacks Rank #1 (Strong Buy) with +25% average annual return since 1988.
- Forward P/E of 7.97 is discounted versus industry average of 10.17.
- PEG ratio of 0.42 is well below industry average of 2.01.
- Insurance sector ranks in top 16% with Zacks Industry Rank of 38.
- Top industries outperform bottom half by factor of 2 to 1.
- Consensus EPS projection rose 2.36% in past 30 days.
Risk Factors
- Stock dropped 1.56%, lagging S&P 500's 0.72% gain.
- Shares fell 2.94% this month despite sector strength.
- Earnings expected April 29, 2026, creating uncertainty.
- EPS forecast shows -25.32% year-over-year contraction.
- Forward P/E of 7.97 signals valuation discount.
- Rank #1 buy rating conflicts with earnings downside pressure.
Bullish Signals
- The investment community anticipates Allstate to report an EPS of $7.7 on April 29, 2026, which would represent a 118.13% rise compared to the same quarter of the previous year.
- Analysts forecast quarterly revenue of $17.72 billion, indicating a 5.49% increase from the year-ago period.
- Allstate currently holds a Zacks Rank of #1 (Strong Buy), which historically delivers an average annual return of +25% since 1988 for stocks in this category.
- The company's Forward P/E ratio of 7.97 signifies a discount compared to the industry average of 10.17, suggesting undervaluation relative to peers.
- Allstate's PEG ratio of 0.42 is significantly lower than the industry average of 2.01, highlighting an attractive valuation adjusted for earnings growth.
- The Insurance - Property and Casualty industry ranks in the top 16% of all industries with a Zacks Industry Rank of 38.
- Research indicates that top-rated industries outperform the bottom half by a factor of 2 to 1, positioning Allstate within a strong performing sector.
- Within the past 30 days, the consensus EPS projection for Allstate has moved 2.36% higher, reflecting evolving positive analyst sentiment.
Risk Factors
- Allstate stock declined 1.56% today, significantly underperforming the S&P 500 which gained 0.72%.
- Shares lost 2.94% over the past month despite outperforming the broader Finance sector's loss of 5.41%, indicating relative weakness in a positive market environment.
- The company is scheduled to release its earnings on April 29, 2026, leaving investors uncertain about future performance guidance.
- Zacks Consensus Estimates forecast annual earnings of $26.01 per share with a year-over-year change of -25.32%, indicating anticipated earnings contraction.
- The Forward P/E ratio of 7.97 suggests a valuation discount, which may signal growth concerns or overreaction to positive prospects.
- With a Zacks Rank of #1 (Strong Buy) and recent EPS projection revisions moving 2.36% higher, the stock appears fundamentally strong yet faces downside pressure from earnings expectations.
Zacks Investment Research analyzes Allstate Corporation (ALL) as a potential value stock based on the combination of its strong Zacks Rank and excellent valuation metrics. The article highlights that Allstate currently holds a Zacks Rank of #1, which is designated as a Strong Buy rating, alongside an "A" grade in their Value category. This dual designation identifies it as one of the highest-quality value stocks available in the market according to Zacks' investment criteria. The analysis emphasizes that value investing focuses on earnings estimates and estimate revisions, and Allstate fits this profile by demonstrating a solid cash outlook and undervalued trading price relative to its industry peers.
From a quantitative perspective, Allstate appears significantly undervalued when compared to industry averages across several key financial ratios. The stock is trading with a Price-to-Earnings (P/E) ratio of 9.21, which stands in sharp contrast to the industry's average P/E of 25.87. Additionally, the company has a Price-to-Sales (P/S) ratio of 0.79, compared to an industry average of 1.3, indicating that its sales are not reflected in its price as highly as competitors. Looking at cash flow, Allstate's Price-to-Cash-Flow (P/CF) ratio is 8.66 against an industry benchmark of 11.46, further supporting the thesis that the stock is currently trading below its intrinsic value.
Historical data over the past 52 weeks reinforces this undervaluation assessment. Allstate's Forward P/E has fluctuated between a high of 11.84 and a low of 8.78, with a median of 10.15. Similarly, the stock's P/CF ratio ranged from as high as 14.16 to as low as 8.07 over the same period, yielding a median of 10.58. The current trading levels are well below these historical highs and are closer to the lower end of the range, suggesting an attractive entry point. With these favorable metrics combined with strong earnings estimates, the article concludes that Allstate represents an impressive value investment opportunity right now for investors seeking high-quality stocks with strong growth potential.
📈 Allstate holds a Zacks #1 Strong Buy rank with solid earnings revisions.
💎 Valuation metrics like P/E and P/S show the stock is significantly undervalued.
💵 Low price-to-cash-flow ratio indicates strong operating cash flow relative to peers.
📈 Allstate (ALL) holds a Zacks Rank #1, indicating a "Strong Buy" rating based on earnings estimates and revisions.
💎 The stock carries an "A" grade within Zacks' Value category, signaling strong value-investment appeal.
🏦 Current P/E ratio of 9.21 is significantly lower than the industry average of 25.87.
📉 Forward P/E has ranged from 8.78 to 11.84 over the past year with a median of 10.15.
💰 Price-to-Sales ratio stands at 0.79, compared to the industry average of 1.3.
🏆 Revenue is highlighted as a stable metric that cannot be easily manipulated by management.
💵 Allstate's P/CF ratio is 8.66 against an industry average of 11.46.
📊 The P/CF metric assesses operating cash flow, which supports the company's solid cash outlook.
📈 Historical P/CF range over 52 weeks spans from a low of 8.07 to a high of 14.16 with a median of 10.58.
🎯 Combined valuation metrics suggest the stock is currently undervalued relative to peers.
🚀 Strength in earnings outlook further supports the attractiveness of ALL as an investment.
💡 Zacks recommends combining its Rank system with Style Scores for identifying high-quality stocks.
Bullish Signals
- Allstate holds a Zacks #1 Strong Buy rating.
- Company has an 'A' Value grade for high quality.
- P/E ratio of 9.21 trades below 25.87 industry average.
- P/S ratio of 0.79 is well under 1.3 peer average.
- P/CF ratio of 8.66 shows value versus 11.46 peers.
Risk Factors
- Low P/E of 9.21 may signal high market risk concerns.
- Skepticism about earnings stability versus a 25.87 industry average.
- P/S ratio of 0.79 is below the 1.3 industry average.
- Investor doubt regarding revenue growth prospects relative to peers.
Bullish Signals
- Allstate (ALL) has a Zacks Rank of #1, which is the highest possible rating indicating Strong Buy potential.
- The stock carries an 'A' grade for Value, positioning it as one of the highest-quality value stocks on the market today.
- With a P/E ratio of 9.21, Allstate trades significantly below its industry average of 25.87, highlighting strong undervaluation.
- The P/S ratio of 0.79 is well below the industry average of 1.3, suggesting revenue is priced attractively.
- Allstate's P/CF ratio of 8.66 is attractive compared to the industry average of 11.46, indicating solid cash flow and value.
Risk Factors
- Allstate trades at a significantly discounted P/E ratio of 9.21 compared to its industry average of 25.87, which may signal that the market perceives higher-than-average risks or concerns regarding future earnings stability.
- The stock's P/S ratio of 0.79 is substantially lower than the industry average of 1.3, potentially indicating investor skepticism about revenue growth prospects relative to peers.
This article from March 27, 2026, published by Zacks.com, highlights five stocks identified using a relative price strength strategy suitable for current market conditions. The broader economic backdrop is described as tense, with oil prices surging due to Middle East uncertainty and mixed signals regarding inflation and economic momentum. Despite these macroeconomic headwinds, the article notes market resilience driven by hopes of diplomatic de-escalation and potential central bank intervention. In this volatile environment, the strategy focuses on stocks that demonstrate relative price strength—specifically those outperforming their industry peers or the S&P 500 over a period of at least one to three months while maintaining solid fundamentals and positive analyst estimate revisions for Q1 earnings.
The five specific recommendations are The Allstate Corp. (ALL), Five Below (FIVE), Archrock (AROC), BrightSpring Health Services (BTSG), and The Beachbody Co. (BODI). Allstate, headquartered in Northbrook, IL, is the third-largest property-casualty insurer with an expected three- to five-year EPS growth rate of 19% against an industry average of 7.7%; its earnings consensus estimates have moved up 7.5% over the past 60 days. Five Below, a Philadelphia-based retailer, shows fiscal 2027 earnings growth estimated at 17.5% with its consensus estimate rising 16.2% recently; shares have gained 200.1% in a year. Archrock, an energy infrastructure company based in Houston, TX, targets 5.8% earnings growth for 2026 with a market cap around $6.5 billion and recent share gains of 37.2%.
BrightSpring Health Services, operating in home-based healthcare, shows robust fundamentals with a Zacks Consensus Estimate for 2026 earnings indicating 61% growth and an upward revision of 15% over the past 60 days; it holds a market capitalization of $8.4 billion. The Beachbody Company, a digital fitness and wellness provider based in Tempe, AZ (implied by standard knowledge but not explicitly stated in the text, sticking strictly to provided info: "The Beachbody Company has a market capitalization of $80.6 million"), is expected to have 10% earnings growth for 2026 with a significant track record of beating earnings estimates at an average of 144.6% over the last four quarters and shares surging 54% in a year. All five companies are noted to have favorable VGM Scores, ranging from A to B, reflecting their quality within the Zacks framework.
The article concludes by promoting Zacks Investment Research's track record since 2000, stating that their top stock-picking strategies have outperformed the S&P's average annual gain of +7.7%, with specific years showing gains of +48.4%, +50.2%, and +56.7%. The summary directs readers to visit Zacks.com for live picks without cost or obligation, noting a standard disclosure that company officers or employees may own interests in the recommended securities.
🌍 Geopolitical oil tensions drive market volatility despite resilience.
🎯 Focus on relative price strength and companies beating peers.
🏢 Allstate, Five Below, Archrock, BrightSpring, and Beachbody offer specific growth targets.
📈 Zacks strategies historically outperformed the S&P 500 by +7.7% annually.
📉 Markets face tension with surging oil prices due to Middle East uncertainty and geopolitical concerns.
🤝 Despite volatility, markets show resilience as hopes for de-escalation help stocks rebound.
🎯 Relative price strength is highlighted as a valuable strategy during choppy market phases.
💰 Investors should focus on companies outperforming peers or the industry average.
📈 Stocks delivering better than S&P 500 for 1-3 months with solid fundamentals indicate growth potential.
🔍 Analyst optimism and positive earnings estimate revisions are crucial indicators for stock selection.
🏢 The Allstate Corporation is the third-largest P&C insurer with expected EPS growth of 19%.
🛒 Five Below offers merchandise at $5 or below and shows 17.5% earnings growth for fiscal 2027.
⛽ Archrock is an energy infrastructure company focused on natural gas compression with 5.8% earnings growth.
🏥 BrightSpring Health Services provides healthcare services with a projected 61% earnings growth rate.
💪 The Beachbody Company is a digital fitness provider indicating 10% earnings growth for 2026.
📊 Allstate shares lost 2.2% in a year while beating earnings estimates by an average of 54.3%.
🚀 Five Below shares surged 200.1% in a year with consensus estimates moving up 16.2%.
🌡 Archrock shares gained 37.2% in a year as market cap is around $6.5 billion.
⚕ BrightSpring Health Services has a market capitalization of $8.4 billion and estimates up 15%.
✨ The Beachbody Company has a market cap of $80.6 million with earnings beats averaging 144.6%.
📈 Zacks top stock-picking strategies have historically outperformed the S&P by +7.7% average gain per year since 2000.
Bullish Signals
- Allstate: VGM A, expected 3-5 yr EPS growth 19% vs industry 7.7%.
- Allstate beat estimates 4 quarters avg +54.3%; consensus up 7.5% in 60 days.
- Five Below: VGM B, 17.5% 2027 growth; consensus +16.2% in 60 days.
- Five Below shares up 200.1% yr; avg earnings beat 63.4% over 4 quarters.
- Archrock: VGM B, strong optimism with 2026 consensus estimate up 9.8% in 60 days.
- BrightSpring Health: VGM A, 61% projected 2026 earnings growth.
- BrightSpring consensus jumped 15% in 60 days; shares +143% to $8.4B cap.
Risk Factors
- Rising oil prices and Middle East uncertainty weigh on growth.
- Mixed inflation signals create volatile market conditions for investors.
- Allstate shares fell 2.2% despite positive earnings expectations.
- Five Below's high 17.5% growth projection faces scrutiny.
- Archrock's 5.8% earnings growth vulnerable to oil price volatility.
- Health Services faces payment delays from Medicare/Medicaid payors.
- Beachbody's $80.6M market cap limits downturn resilience.
- Stocks face downside risk if analyst estimates are missed.
Bullish Signals
- The Allstate Corp. has a VGM Score of A and an expected EPS growth rate for three to five years of 19%, significantly outperforming the industry average of 7.7%.
- Allstate has beaten the Zacks Consensus Estimate for earnings in each of the last four quarters with an average beat of 54.3%. The company's earnings consensus estimate has moved up 7.5% over the past 60 days.
- Five Below has a VGM Score of B and indicates 17.5% growth for fiscal 2027, while its earnings consensus estimate has increased by 16.2% over the last 60 days.
- Five Below has demonstrated exceptional momentum with shares surging 200.1% in a year and an average earnings beat of 63.4% over the last four quarters.
- Archrock has a VGM Score of B and shows strong analyst optimism as its 2026 earnings consensus estimate grew up 9.8% in the past 60 days.
- BrightSpring Health Services has a VGM Score of A with an impressive Zacks Consensus Estimate indicating 61% earnings growth for 2026.
- BrightSpring's earnings consensus estimate has jumped up 15% over the past 60 days, driving shares up 143% in a year to a market cap of $8.4 billion.
- The Beachbody Company holds a VGM Score of A and beat its Zacks Consensus Estimate for earnings in each of the last four quarters with an average beating of 144.6%.
- Beachbody has achieved impressive performance metrics including a market cap of $80.6 million and shares gaining 54% in a year with 10% projected earnings growth for 2026.
Risk Factors
- Oil prices are surging due to Middle East uncertainty, with reports of troop deployments and stalled negotiations that initially pulled stocks lower and could weigh on growth.
- Investors face mixed signals regarding inflation and economic momentum, creating a tricky balance for policymakers that may lead to volatile market conditions.
- The Allstate Corporation shares have lost 2.2% in a year, which contrasts with the positive earnings expectations presented in the article.
- Five Below's valuation indicates 17.5% growth for fiscal 2027, which is significantly higher than the industry average and could face scrutiny from investors wary of such high projections.
- Archrock's earnings growth expectation of 5.8% for 2026 may be vulnerable to further volatility in oil and gas prices if the Middle East situation does not stabilize.
- BrightSpring Health Services relies on Medicare, Medicaid and commercial payors, exposing it to potential payment delays or reimbursement cuts from government programs.
- The Beachbody Company has a relatively small market capitalization of $80.6 million compared to larger peers, which could limit its ability to withstand market downturns or competitive pressures.
- Analysts' optimism about upcoming earnings is contingent on positive estimate revisions, but if these are not met, it could lead to significant downside risk for the highlighted stocks.
Investors holding Allstate's fixed-to-floating rate subordinated debt are anticipating a pivotal disclosure regarding the company's first-quarter 2026 results, scheduled for release on Wednesday, April 29, 2026. This upcoming report is expected to serve as a critical barometer for the insurance giant's financial resilience, shifting market focus from purely market-driven interest payments to an evaluation of Allstate's core operational strength. Following a robust fiscal year in 2025 where the company posted a net profit of $10.2 billion on revenue of $67.7 billion, and prior quarterly earnings of $14.31 per share in Q4 2025, these figures will provide context for evaluating Allstate's near-term operational trajectory and its capacity to meet long-term obligations. Market observers have projected earnings of $7.35 per share for the opening quarter of 2026, though the final data is awaited to confirm the effectiveness of the company's strategy to capture market share in property and casualty insurance alongside observed claims ratios for the early months of the year.
A significant element of scrutiny involves Allstate's specific class of subordinated debentures that transitioned into a variable interest rate phase at the beginning of 2023. The coupon for these instruments is calculated based on the three-month LIBOR plus a fixed spread of 3.165 percent, meaning prevailing market rates directly dictate the size of quarterly payments and influence investor sentiment. In parallel, the company's related securities saw a dividend of $0.4437 per share declared on March 18, with payment set for April 15; this payout represents a decrease compared to the previous distribution, offering income-focused investors a meaningful signal regarding Allstate's current capital allocation priorities and its approach to managing cash flows amidst dynamic market conditions.
The convergence of these factors—the variable bond payments driven by fluctuating rates and the highly anticipated quarterly earnings release—places Allstate's financial discipline and structural stability squarely in the spotlight. Investors are using this period to assess whether the company can maintain its growth trajectory while navigating a shifting interest rate environment that impacts its capital structure. While recent reports indicate fresh Allstate 5100 Fixed-To-Floating Rate Subordinated Debentures due information has been released, independent market analyses are examining these figures to determine the impact on investors, specifically considering whether current valuations suggest an opportunity for entry or if immediate caution is warranted given the evolving economic landscape.
📅 Q1 2026 results release scheduled for April 29, 2026.
💰 Analysts project $7.35 earnings per share for the quarter.
🏦 Variable interest debt now relies on three-month LIBOR plus spread.
📉 Recent dividend declared is lower than previous distributions.
🚀 Investors monitor cash flows to assess financial resilience and stability.
📅 Allstate is scheduled to release its Q1 2026 financial results on April 29, 2026.
💰 Analysts project earnings of $7.35 per share for the upcoming quarter.
📉 The prior fiscal year (2025) saw a net profit of $10.2 billion on $67.7 billion in revenue.
🚀 Q4 2025 earnings were even stronger at $14.31 per share before this reporting period.
🏦 A specific class of Allstate's subordinated debentures entered a variable interest rate phase in early 2023.
📊 Current coupon rates on these instruments are calculated using three-month LIBOR plus 3.165 percent.
💸 A dividend of $0.4437 per share was declared on March 18 for a related security tranche.
📉 The declared dividend represents a decrease compared to previous distributions paid out.
⚠️ Investors are closely watching cash flows and capital allocation priorities signaled by these payments.
🏢 The upcoming report will reveal Allstate's ability to capture property and casualty market share.
📈 Claims ratios observed in early 2026 will provide insights into operational effectiveness.
⏳ Market observers view the results as a key barometer for the company's financial resilience.
💹 Fixed-to-floating rate instruments make payments dependent on prevailing market rates rather than fixed amounts.
🔍 The convergence of variable bond payments and earnings releases highlights Allstate's structural stability.
❓ Independent reports are currently analyzing figures to determine if investors should sell or buy these debentures.
Bullish Signals
- Allstate posted a robust fiscal year 2025 with net profit of $10.2 billion on revenue of $67.7 billion.
- The prior quarter, Q4 2025, saw exceptionally strong per-share earnings of $14.31, indicating sustained high-level performance.
- Market observers project first-quarter 2026 earnings of $7.35 per share, reflecting positive expectations for the company's operational trajectory.
- A dividend of $0.4437 per share was declared on March 18 for the related security tranche, with payment scheduled for April 15.
- Allstate continues to demonstrate financial resilience and capacity to reliably meet long-term obligations in a dynamic market environment.
Risk Factors
- The dividend for the relevant security has been declared at $0.4437 per share with a payment date of April 15, representing a decrease compared to previous distributions.
- Market observers are projecting Q1 2026 earnings of $7.35 per share following the significantly higher $14.31 per share reported in Q4 2025, indicating a potential quarter-over-quarter decline in performance.
